Protein Delivery Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global protein delivery market looks promising with opportunities in the metabolic disorders, immunologic disorders, hematological disorders, cancer, hormonal disorders, and genetic disorders. The global protein delivery market is expected to grow with a CAGR of 6%-8% from 2020 to 2025. The major drivers for this market are increasing prevalence of chronic diseases and increasing awareness on high efficiency of protein therapeutics with the minimum risk of side effects.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global protein delivery market report, please download the report brochure.
protein delivery
In this market, monoclonal antibodies is the largest product of protein delivery, whereas metabolic disorders is the largest application. Growth in various segments of the protein delivery market are given below:
protein delivery
The study includes trends and forecast for the global protein delivery market by product, application, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Monoclonal AntibodiesInsulinFusion ProteinErythropoietinInterferonHuman Growth HormoneFollicle Stimulating Hormone
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Metabolic DisordersImmunologic DisordersHematological DisordersCancerHormonal DisordersGenetic DisordersOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the World Brazil
Some of the protein delivery companies profiled in this report include Abbott Laboratories, Amgen, Baxter International, Eli Lilly and Company, F. Hoffmann-La Roche, Johnson & Johnson, Merck & Co., Novo Nordisk, Pfizer, and Sanofi.
Lucintel forecasts that monoclonal antibodies will remain the largest segment over the forecast period as it is used in the treatment of different chronic disorders.
Within this market, metabolic disorders will remain the largest segment by application over the forecast period due to the introduction of patient support programs related to treatment of various metabolic disorders.
Asia-Pacific will remain the fastest growing region over the forecast period due to increasing awareness of people on protein therapeutic-based treatments and rising protein therapeutic applications.
Features of the Global Protein Delivery Market
Market Size Estimates: Global protein delivery market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global protein delivery market size by various segments, such as product and application in terms of value.Regional Analysis: Global protein delivery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, application, and region for the global protein delivery market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global protein delivery market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global protein delivery market by product monoclonal antibodies, insulin, fusion protein, erythropoietin, interferon, human growth hormone, and follicle stimulating hormone), application (metabolic disorders, immunologic disorders, hematological disorders, cancer, hormonal disorders, genetic disorders, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global protein delivery market?
Q.5 What are the business risks and threats to the global protein delivery market?
Q.6 What are the emerging trends in this protein delivery market and the reasons behind them?
Q.7 What are some changing demands of customers in this protein delivery market?
Q.8 What are the new developments in this protein delivery market? Which companies are leading these developments?
Q.9 Who are the major players in this protein delivery market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this protein delivery market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global protein delivery market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global protein delivery market looks promising with opportunities in the metabolic disorders, immunologic disorders, hematological disorders, cancer, hormonal disorders, and genetic disorders. The global protein delivery market is expected to grow with a CAGR of 6%-8% from 2020 to 2025. The major drivers for this market are increasing prevalence of chronic diseases and increasing awareness on high efficiency of protein therapeutics with the minimum risk of side effects.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global protein delivery market report, please download the report brochure.
protein delivery
In this market, monoclonal antibodies is the largest product of protein delivery, whereas metabolic disorders is the largest application. Growth in various segments of the protein delivery market are given below:
protein delivery
The study includes trends and forecast for the global protein delivery market by product, application, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Monoclonal AntibodiesInsulinFusion ProteinErythropoietinInterferonHuman Growth HormoneFollicle Stimulating Hormone
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Metabolic DisordersImmunologic DisordersHematological DisordersCancerHormonal DisordersGenetic DisordersOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the World Brazil
Some of the protein delivery companies profiled in this report include Abbott Laboratories, Amgen, Baxter International, Eli Lilly and Company, F. Hoffmann-La Roche, Johnson & Johnson, Merck & Co., Novo Nordisk, Pfizer, and Sanofi.
Lucintel forecasts that monoclonal antibodies will remain the largest segment over the forecast period as it is used in the treatment of different chronic disorders.
Within this market, metabolic disorders will remain the largest segment by application over the forecast period due to the introduction of patient support programs related to treatment of various metabolic disorders.
Asia-Pacific will remain the fastest growing region over the forecast period due to increasing awareness of people on protein therapeutic-based treatments and rising protein therapeutic applications.
Features of the Global Protein Delivery Market
Market Size Estimates: Global protein delivery market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global protein delivery market size by various segments, such as product and application in terms of value.Regional Analysis: Global protein delivery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, application, and region for the global protein delivery market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global protein delivery market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global protein delivery market by product monoclonal antibodies, insulin, fusion protein, erythropoietin, interferon, human growth hormone, and follicle stimulating hormone), application (metabolic disorders, immunologic disorders, hematological disorders, cancer, hormonal disorders, genetic disorders, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global protein delivery market?
Q.5 What are the business risks and threats to the global protein delivery market?
Q.6 What are the emerging trends in this protein delivery market and the reasons behind them?
Q.7 What are some changing demands of customers in this protein delivery market?
Q.8 What are the new developments in this protein delivery market? Which companies are leading these developments?
Q.9 Who are the major players in this protein delivery market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this protein delivery market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global protein delivery market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Protein Delivery Market Trends and Forecast
3.3: Global Protein Delivery Market by Product
3.3.1: Monoclonal Antibodies
3.3.2: Insulin
3.3.3: Fusion Protein
3.3.4: Erythropoietin
3.3.5: Interferon
3.3.6: Human Growth Hormone
3.3.7: Follicle Stimulating Hormone
3.4: Global Protein Delivery Market by Application
3.4.1: Hematological Disorders
3.4.2: Immunologic Disorderl
3.4.3: Hematological Disordersl
3.4.4: Cancer
3.4.5: Hormonal Disorders
3.4.6: Genetic Disorders
3.4.7: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Protein Delivery Market by Region
4.2: North American Protein Delivery Market
4.2.1: Market by Product: Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone
4.2.2: Market by Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others
4.2.3: Market by Species: Fish, Crustaceans, and Mollusks
4.2.4: The United States Protein Delivery Market
4.2.5: The Canadian Protein Delivery Market
4.2.6: The Mexican Protein Delivery Market
4.3: European Protein Delivery Market
4.3.1: Market by Product: Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone
4.3.2: Market by Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others
4.3.3: The Protein Delivery Market of United Kingdom
4.3.4: The Spanish Protein Delivery Market
4.3.5: The German Protein Delivery Market
4.3.6: The French Protein Delivery Market
4.4: APAC Protein Delivery Market
4.4.1: Market by Product: Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone
4.4.2: Market by Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others
4.4.3: The Chinese Protein Delivery Market
4.4.4: The Indian Protein Delivery Market
4.4.5: The Japanese Protein Delivery Market
4.5: ROW Protein Delivery Market
4.5.1: Market by Product: Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone
4.5.2: Market by Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others
4.5.3: Brazilian Protein Delivery Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Protein Delivery Market by Product
7.1.2: Growth Opportunities for the Global Protein Delivery Market by Application
7.1.3: Growth Opportunities for the Global Protein Delivery Market by Region
7.2: Emerging Trends in the Global Protein Delivery Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Protein Delivery Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Protein Delivery Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Abbott LaboratoriesAmgen Inc.
8.2: Amgen Inc.
8.3: Baxter International Inc.
8.4: Eli Lilly and Company
8.5: F. Hoffmann-La Roche Ltd.
8.6: Johnson & Johnson
8.7: Merck & Co., Inc.
8.8: Nov Nordisk A/S
8.9: Pfizer Inc.
8.10: Sanofi
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Protein Delivery Market Trends and Forecast
3.3: Global Protein Delivery Market by Product
3.3.1: Monoclonal Antibodies
3.3.2: Insulin
3.3.3: Fusion Protein
3.3.4: Erythropoietin
3.3.5: Interferon
3.3.6: Human Growth Hormone
3.3.7: Follicle Stimulating Hormone
3.4: Global Protein Delivery Market by Application
3.4.1: Hematological Disorders
3.4.2: Immunologic Disorderl
3.4.3: Hematological Disordersl
3.4.4: Cancer
3.4.5: Hormonal Disorders
3.4.6: Genetic Disorders
3.4.7: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Protein Delivery Market by Region
4.2: North American Protein Delivery Market
4.2.1: Market by Product: Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone
4.2.2: Market by Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others
4.2.3: Market by Species: Fish, Crustaceans, and Mollusks
4.2.4: The United States Protein Delivery Market
4.2.5: The Canadian Protein Delivery Market
4.2.6: The Mexican Protein Delivery Market
4.3: European Protein Delivery Market
4.3.1: Market by Product: Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone
4.3.2: Market by Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others
4.3.3: The Protein Delivery Market of United Kingdom
4.3.4: The Spanish Protein Delivery Market
4.3.5: The German Protein Delivery Market
4.3.6: The French Protein Delivery Market
4.4: APAC Protein Delivery Market
4.4.1: Market by Product: Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone
4.4.2: Market by Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others
4.4.3: The Chinese Protein Delivery Market
4.4.4: The Indian Protein Delivery Market
4.4.5: The Japanese Protein Delivery Market
4.5: ROW Protein Delivery Market
4.5.1: Market by Product: Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone
4.5.2: Market by Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others
4.5.3: Brazilian Protein Delivery Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Protein Delivery Market by Product
7.1.2: Growth Opportunities for the Global Protein Delivery Market by Application
7.1.3: Growth Opportunities for the Global Protein Delivery Market by Region
7.2: Emerging Trends in the Global Protein Delivery Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Protein Delivery Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Protein Delivery Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Abbott LaboratoriesAmgen Inc.
8.2: Amgen Inc.
8.3: Baxter International Inc.
8.4: Eli Lilly and Company
8.5: F. Hoffmann-La Roche Ltd.
8.6: Johnson & Johnson
8.7: Merck & Co., Inc.
8.8: Nov Nordisk A/S
8.9: Pfizer Inc.
8.10: Sanofi
